Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33)
| קרן | National Cancer Institute/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 29/09/2020 |
| פקולטה | Engineering, Exact Sciences, Life Sciences, Medicine |
| תיאור | applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care. R33 supports Phase II of an exploratory/developmental Grant.
Funding: $300,000 per year Duration: 3 years
Research Authority due date: 10 days prior to submission LOI (encouraged) due date: 21.1.20, 28.4.20, 29.8.20 Full proposal due date: 21.2.20, 28.5.20, 29.9.20 |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 05/12/2019 |
